Logotype for Arteris Inc

Arteris (AIP) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Arteris Inc

Q3 2024 earnings summary

16 Jan, 2026

Executive summary

  • Achieved record annual contract value plus royalties of $60.5 million in Q3 2024, up 6% year-over-year, driven by strong demand for AI-driven enterprise computing, automotive SoC solutions, and expanded adoption among top-tier customers.

  • Positive free cash flow of $1.1 million for the third consecutive quarter, reflecting effective cost management and operational execution.

  • Expanded customer base and product adoption, including a top five global technology company, leading automotive and AI chip companies, and new wins in data center and microcontroller markets.

  • Introduced NoC tiling innovation to accelerate AI SoC design, with significant customer interest and expected revenue impact in 2025.

  • Strengthened leadership with new Board and executive appointments, including Joachim Kunkel and Ken Way.

Financial highlights

  • Q3 2024 revenue was $14.7 million, up 11% year-over-year and at the midpoint of guidance.

  • GAAP gross profit was $13.3 million (90% margin); non-GAAP gross profit was $13.5 million (92% margin).

  • GAAP operating loss was $7.9 million, improved from $8.5 million a year ago; non-GAAP operating loss was $3.3 million, a $1.2 million year-over-year improvement.

  • Net loss was $7.7 million (GAAP) and $3.1 million (non-GAAP); diluted net loss per share was $0.20 (GAAP) and $0.08 (non-GAAP).

  • Ended Q3 with $54.5 million in cash, cash equivalents, and investments.

Outlook and guidance

  • Q4 2024 guidance: ACV plus royalties of $63M–$67M, revenue of $14.7M–$15.7M, non-GAAP operating loss of $5M–$4M, and non-GAAP free cash flow of -$0.9M to $1.1M.

  • Full year 2024 guidance: ACV plus royalties of $63M–$67M (up over 16% YoY at midpoint), revenue of $56.9M–$57.9M, non-GAAP operating loss of $17.1M–$16.1M, and non-GAAP free cash flow of $0.7M–$2.7M.

  • Improved guidance for revenue, operating income, and free cash flow for the full year.

  • Management expects continued investment in R&D and global expansion, with R&D expenses anticipated to increase as a percentage of revenue in the near term.

  • Cash, cash equivalents, and investments are expected to be sufficient to meet operational needs for at least the next 12 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more